(-)-alpha-phellandrene decreases expression ISO CYP51A1 (Homo sapiens) 6480464 alpha phellandrene results in decreased expression of CYP51 mRNA CTD PMID:25075043 (-)-epigallocatechin 3-gallate increases expression ISO CYP51A1 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of CYP51A1 mRNA CTD PMID:32512070 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression EXP 6480464 o and p'-DDT affects the expression of CYP51 mRNA CTD PMID:18925944 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of CYP51 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of CYP51 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine affects expression EXP 6480464 1 and 2-Dimethylhydrazine affects the expression of CYP51 mRNA CTD PMID:22206623 1-(3-(trifluoromethyl)phenyl)piperazine increases expression ISO Cyp51 (Rattus norvegicus) 6480464 1-(3-trifluoromethylphenyl)piperazine results in increased expression of CYP51 mRNA CTD PMID:26821219 1-benzylpiperazine increases expression ISO Cyp51 (Rattus norvegicus) 6480464 N-benzylpiperazine results in increased expression of CYP51 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate increases expression ISO Cyp51 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CYP51 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Ethinyl Estradiol affects the expression of CYP51 mRNA CTD PMID:17351261 17alpha-ethynylestradiol decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of CYP51 mRNA CTD PMID:17108234 17beta-estradiol increases expression ISO CYP51A1 (Homo sapiens) 6480464 Estradiol results in increased expression of CYP51A1 mRNA CTD PMID:19167446 17beta-estradiol affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Estradiol affects the expression of CYP51 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of CYP51 mRNA CTD PMID:29367455 1H-pyrazole increases expression EXP 6480464 pyrazole results in increased expression of CYP51 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 and PMID:30722647 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO CYP51A1 (Homo sapiens) 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP51 mRNA CTD PMID:26232522 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP51 mRNA CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP51 mRNA CTD PMID:21215274 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression ISO Cyp51 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of CYP51 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO Cyp51 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of CYP51 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Itraconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Itraconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Itraconazole CTD PMID:18694951 2-hydroxypropanoic acid increases expression ISO CYP51A1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of CYP51A1 mRNA CTD PMID:30851411 22-Hydroxycholesterol decreases expression ISO CYP51A1 (Homo sapiens) 6480464 22-hydroxycholesterol results in decreased expression of CYP51A1 mRNA CTD PMID:19426978 24,25-dihydrolanosterol decreases abundance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 mRNA results in decreased abundance of lanostenol CTD PMID:23125191 3',5'-cyclic AMP increases expression EXP 6480464 Cyclic AMP results in increased expression of CYP51 mRNA CTD PMID:25576683 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp51 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of CYP51 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CYP51 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO CYP51A1 (Homo sapiens) 6480464 bisphenol S results in increased expression of CYP51A1 protein CTD PMID:34186270 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of CYP51 mRNA CTD PMID:34850234 4,4'-sulfonyldiphenol affects expression ISO CYP51A1 (Homo sapiens) 6480464 bisphenol S affects the expression of CYP51A1 protein CTD PMID:31945527 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Fadrozole results in decreased activity of CYP51A1 protein CTD PMID:16989930 4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine increases expression EXP 6480464 fenpropimorph results in increased expression of CYP51 mRNA CTD PMID:34737147 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of CYP51A1 mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of CYP51 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CYP51 mRNA CTD PMID:30047161 8-Br-cAMP increases expression ISO CYP51A1 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP51A1 mRNA CTD PMID:22079614 8-Br-cAMP multiple interactions EXP 6480464 [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA more ... CTD PMID:18467523 acetamide decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 acetamide results in decreased expression of CYP51 mRNA CTD PMID:31881176 acetohydrazide increases expression EXP 6480464 acetylhydrazine results in increased expression of CYP51 mRNA CTD PMID:15282401 Acetyl tributyl citrate decreases expression EXP 6480464 2-acetyltributylcitrate results in decreased expression of CYP51 mRNA CTD PMID:37055963 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP51 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP51A1 mRNA CTD PMID:27153756 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO CYP51A1 (Homo sapiens) 6480464 Tretinoin results in increased expression of CYP51A1 mRNA CTD PMID:33167477 alpha-hexachlorocyclohexane increases expression ISO Cyp51 (Rattus norvegicus) 6480464 alpha-hexachlorocyclohexane results in increased expression of CYP51 mRNA CTD PMID:17785943 alpha-phellandrene decreases expression ISO CYP51A1 (Homo sapiens) 6480464 alpha phellandrene results in decreased expression of CYP51 mRNA CTD PMID:25075043 amitrole increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Amitrole results in increased expression of CYP51 mRNA CTD PMID:30047161 ammonium chloride affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CYP51 mRNA CTD PMID:16483693 arsane affects methylation ISO CYP51A1 (Homo sapiens) 6480464 Arsenic affects the methylation of CYP51A1 gene CTD PMID:25304211 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP51 mRNA CTD PMID:32045263 arsenic atom affects methylation ISO CYP51A1 (Homo sapiens) 6480464 Arsenic affects the methylation of CYP51A1 gene CTD PMID:25304211 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP51 mRNA CTD PMID:32045263 benzalkonium chloride increases expression EXP 6480464 Benzalkonium Compounds results in increased expression of CYP51 mRNA CTD PMID:31199489 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP51A1 mRNA and Benzo(a)pyrene results in increased expression of CYP51A1 protein CTD PMID:20127859 and PMID:34472326 benzo[a]pyrene decreases methylation ISO CYP51A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of CYP51A1 5' UTR and Benzo(a)pyrene results in decreased methylation of CYP51A1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP51A1 mRNA CTD PMID:21632981 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP51 mRNA CTD PMID:19770486 and PMID:22228805 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of CYP51 mRNA CTD PMID:17178593 beta-naphthoflavone multiple interactions EXP 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of CYP51 mRNA] CTD PMID:22234961 beta-naphthoflavone multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA CTD PMID:18164116 beta-naphthoflavone decreases expression ISO CYP51A1 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of CYP51 mRNA CTD PMID:22234961 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of CYP51 mRNA CTD PMID:22234961 bezafibrate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Bezafibrate results in decreased expression of CYP51 mRNA CTD PMID:17719200 bifonazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 bifonazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 more ... bis(2-ethylhexyl) phthalate increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP51 mRNA CTD PMID:37560165 bis(2-ethylhexyl) phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP51 mRNA CTD PMID:26472102 and PMID:33983380 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP51 mRNA CTD PMID:19850644 bisphenol A increases expression ISO Cyp51 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CYP51 mRNA and bisphenol A results in increased expression of CYP51A1 mRNA CTD PMID:12075121 and PMID:25181051 bisphenol A decreases expression ISO CYP51A1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CYP51A1 protein CTD PMID:37567409 bisphenol A affects expression ISO Cyp51 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CYP51 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP51 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO CYP51A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of CYP51A1 mRNA and bisphenol A results in increased expression of CYP51A1 protein CTD PMID:29275510 and PMID:34186270 bisphenol A multiple interactions EXP 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 and PMID:30722647 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP51 mRNA CTD PMID:30566610 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP51 mRNA CTD PMID:25270620 Bisphenol B increases expression ISO CYP51A1 (Homo sapiens) 6480464 bisphenol B results in increased expression of CYP51A1 protein CTD PMID:34186270 bisphenol F increases expression EXP 6480464 4 and 4'-bisphenol F results in increased expression of CYP51 mRNA CTD PMID:25576683 bitertanol decreases activity ISO CYP51A1 (Homo sapiens) 6480464 bitertanol results in decreased activity of CYP51A1 protein CTD PMID:16989930 bromobenzene decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 bromobenzene results in decreased expression of CYP51 mRNA CTD PMID:12628495 and PMID:32479839 Butylbenzyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 butylbenzyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:26472102 cadmium atom multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP51A1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP51A1 mRNA CTD PMID:35301059 carbon nanotube decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Nanotubes and Carbon results in decreased expression of CYP51A1 mRNA CTD PMID:28673683 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carnosic acid decreases expression EXP 6480464 salvin results in decreased expression of CYP51A1 protein CTD PMID:35926579 cerium trichloride affects expression EXP 6480464 cerous chloride affects the expression of CYP51 mRNA CTD PMID:23139204 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of CYP51 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of CYP51 mRNA CTD PMID:37019170 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of CYP51 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of CYP51 mRNA CTD PMID:18353800 cisplatin affects expression ISO CYP51A1 (Homo sapiens) 6480464 Cisplatin affects the expression of CYP51A1 mRNA CTD PMID:27594783 clobetasol increases expression EXP 6480464 Clobetasol results in increased expression of CYP51 mRNA CTD PMID:27462272 clotrimazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Clotrimazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 clotrimazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Clotrimazole CTD PMID:18694951 cobalt dichloride decreases expression ISO CYP51A1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CYP51A1 mRNA CTD PMID:19320972 cocaine decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Cocaine results in decreased expression of CYP51 mRNA CTD PMID:12629581 copper atom decreases expression EXP 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:17205981 copper atom decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:17205981 copper(0) decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Copper results in decreased expression of CYP51 mRNA CTD PMID:30556269 copper(II) chloride decreases expression ISO CYP51A1 (Homo sapiens) 6480464 cupric chloride results in decreased expression of CYP51A1 mRNA CTD PMID:34921933 copper(II) sulfate decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CYP51A1 mRNA CTD PMID:19549813 coumarin decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 coumarin results in decreased expression of CYP51 mRNA CTD PMID:18480146 coumestrol increases expression ISO CYP51A1 (Homo sapiens) 6480464 Coumestrol results in increased expression of CYP51A1 mRNA CTD PMID:19167446 Cuprizon decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of CYP51 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Cyclosporine results in increased expression of CYP51 mRNA CTD PMID:18172885 cyclosporin A increases expression ISO CYP51A1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CYP51A1 mRNA CTD PMID:27989131 cyclosporin A decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP51A1 mRNA CTD PMID:25562108 cyproconazole affects expression EXP 6480464 cyproconazole affects the expression of CYP51 mRNA CTD PMID:22045034 cyproconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 cyproconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP51 mRNA CTD PMID:17998272 dexamethasone multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 dexamethasone affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Dexamethasone affects the expression of CYP51 mRNA CTD PMID:15102944 Di-n-hexyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 di-n-hexyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:33983380 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP51 mRNA CTD PMID:17361019 and PMID:21266533 dibutyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of CYP51 mRNA CTD PMID:17379624 more ... dichloromethane affects expression EXP 6480464 Methylene Chloride affects the expression of CYP51 mRNA CTD PMID:28392392 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CYP51 mRNA CTD PMID:26934552 diclofenac decreases activity EXP 6480464 Diclofenac metabolite results in decreased activity of CYP51A1 protein CTD PMID:28960974 Dicyclohexyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 dicyclohexyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:33983380 difenoconazole increases expression ISO Cyp51 (Rattus norvegicus) 6480464 difenoconazole results in increased expression of CYP51 mRNA CTD PMID:28263823 difenoconazole increases expression EXP 6480464 difenoconazole results in increased expression of CYP51 mRNA CTD PMID:29337257 diisobutyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 diisobutyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:33983380 diisononyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 diisononyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:33983380 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP51 mRNA CTD PMID:30529165 dipentyl phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 di-n-pentyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:26472102 and PMID:33983380 diquat decreases expression EXP 6480464 Diquat results in decreased expression of CYP51 mRNA CTD PMID:36851058 diuron decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Diuron results in decreased expression of CYP51 mRNA CTD PMID:21551480 econazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Econazole CTD PMID:18694951 endosulfan affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Endosulfan affects the expression of CYP51 mRNA CTD PMID:29391264 enilconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 enilconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 epoxiconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 epoxiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 epoxiconazole increases expression ISO CYP51A1 (Homo sapiens) 6480464 epoxiconazole results in increased expression of CYP51A1 mRNA CTD PMID:34182286 ergosterol multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Fluconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 erlotinib hydrochloride increases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 mRNA results in increased susceptibility to Erlotinib Hydrochloride CTD PMID:23125191 ethanol multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of CYP51 mRNA CTD PMID:17347304 ethanol multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP51 mRNA CTD PMID:30517762 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP51 mRNA CTD PMID:19167417 and PMID:30319688 ethyl methanesulfonate decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of CYP51A1 mRNA CTD PMID:23649840 fenarimol increases expression ISO Cyp51 (Rattus norvegicus) 6480464 fenarimol results in increased expression of CYP51 mRNA CTD PMID:28970091 fenarimol increases expression EXP 6480464 fenarimol results in increased expression of CYP51 mRNA CTD PMID:29337257 fipronil increases expression ISO CYP51A1 (Homo sapiens) 6480464 fipronil results in increased expression of CYP51A1 mRNA CTD PMID:27091632 fluconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Fluconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 fluconazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Fluconazole CTD PMID:18694951 fluconazole multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Fluconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 fluoranthene decreases expression EXP 6480464 fluoranthene results in decreased expression of CYP51 mRNA CTD PMID:28329830 flusilazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 flusilazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 flusilazole affects expression EXP 6480464 flusilazole affects the expression of CYP51 mRNA CTD PMID:22634333 flusilazole increases expression ISO Cyp51 (Rattus norvegicus) 6480464 flusilazole results in increased expression of CYP51 mRNA CTD PMID:22664269 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CYP51 mRNA CTD PMID:21192963 more ... flutamide decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CYP51 mRNA CTD PMID:24136188 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of CYP51 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CYP51A1 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of CYP51 mRNA CTD PMID:24183702 gamma-hexachlorocyclohexane increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased expression of CYP51 mRNA CTD PMID:17785943 genistein increases expression EXP 6480464 Genistein results in increased expression of CYP51 mRNA CTD PMID:32186404 gentamycin decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CYP51 mRNA CTD PMID:33387578 glycidol decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 glycidol results in decreased expression of CYP51 mRNA CTD PMID:24915197 hexaconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 hexaconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of CYP51 mRNA CTD PMID:15282401 hydrogen peroxide multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA CTD PMID:18032389 hydrogen peroxide affects expression ISO CYP51A1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of CYP51A1 mRNA CTD PMID:21179406 indometacin multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CYP51A1 mRNA CTD PMID:28628672 isotretinoin decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of CYP51A1 mRNA CTD PMID:20436886 itraconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Itraconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 itraconazole multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Itraconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 itraconazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Itraconazole CTD PMID:18694951 ivermectin increases expression ISO CYP51A1 (Homo sapiens) 6480464 Ivermectin results in increased expression of CYP51A1 protein CTD PMID:32959892 ketoconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 ketoconazole increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Ketoconazole results in increased expression of CYP51 mRNA CTD PMID:28263823 ketoconazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Ketoconazole CTD PMID:18694951 ketoconazole multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol CTD PMID:12617470 ketoconazole multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Ketoconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 ketoconazole increases activity ISO Cyp51 (Rattus norvegicus) 6480464 Ketoconazole results in increased activity of CYP51 protein CTD PMID:12617470 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CYP51 mRNA and Ketoconazole results in increased expression of CYP51 protein CTD PMID:17966066 and PMID:29337257 lanosterol multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol CTD PMID:12617470 lanosterol multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Fluconazole results in decreased metabolism of and results in increased abundance of Lanosterol] more ... CTD PMID:18694951 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of CYP51 mRNA CTD PMID:22293356 lead nitrate increases expression ISO Cyp51 (Rattus norvegicus) 6480464 lead nitrate results in increased expression of CYP51 mRNA CTD PMID:15475176 lead nitrate multiple interactions EXP 6480464 [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA] CTD PMID:22293356 leflunomide increases expression ISO Cyp51 (Rattus norvegicus) 6480464 leflunomide results in increased expression of CYP51 mRNA CTD PMID:24136188 leflunomide decreases expression ISO CYP51A1 (Homo sapiens) 6480464 leflunomide results in decreased expression of CYP51A1 mRNA CTD PMID:28988120 letrozole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 letrozole results in decreased activity of CYP51A1 protein CTD PMID:16989930 levofloxacin increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Levofloxacin results in increased expression of CYP51 mRNA CTD PMID:24136188 limonene increases expression ISO Cyp51 (Rattus norvegicus) 6480464 limonene results in increased expression of CYP51 mRNA CTD PMID:12815608 lithocholic acid decreases expression EXP 6480464 Lithocholic Acid results in decreased expression of CYP51 mRNA CTD PMID:20359477 methapyrilene increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of CYP51 mRNA CTD PMID:30467583 methimazole increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Methimazole results in increased expression of CYP51 mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of CYP51A1 mRNA CTD PMID:23649840 miconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 Miconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 miconazole increases expression EXP 6480464 Miconazole results in increased expression of CYP51 mRNA CTD PMID:27462272 and PMID:29337257 miconazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Miconazole CTD PMID:18694951 mono(2-ethylhexyl) phthalate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP51 mRNA CTD PMID:22087261 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CYP51 mRNA CTD PMID:37364752 N(6)-butyryl-cAMP multiple interactions EXP 6480464 [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA more ... CTD PMID:18467523 N,N-diethyl-m-toluamide multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of CYP51 gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP51 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYP51 mRNA CTD PMID:24535843 N-nitrosodiethylamine decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of CYP51 mRNA CTD PMID:19638242 obeticholic acid decreases expression ISO CYP51A1 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP51A1 mRNA CTD PMID:27939613 ozone increases expression EXP 6480464 Ozone results in increased expression of CYP51 mRNA CTD PMID:12763052 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP51 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP51 mRNA CTD PMID:29246445 paracetamol multiple interactions EXP 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of CYP51 mRNA] CTD PMID:29246445 paracetamol decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP51A1 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Acetaminophen affects the expression of CYP51 mRNA CTD PMID:18246545 paracetamol decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CYP51 mRNA CTD PMID:18246545 more ... penconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 penconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of CYP51 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid decreases expression ISO CYP51A1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP51A1 mRNA CTD PMID:36864359 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP51 mRNA CTD PMID:20936131 perfluorooctanoic acid decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in decreased expression of CYP51 mRNA and perfluorooctanoic acid results in decreased expression of CYP51 protein CTD PMID:19162173 and PMID:34958885 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CYP51A1 mRNA CTD PMID:30508572 perfluorooctanoic acid decreases expression ISO CYP51A1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of CYP51A1 protein CTD PMID:26879310 perfluorooctanoic acid increases expression ISO CYP51A1 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CYP51A1 mRNA CTD PMID:23978341 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP51A1 mRNA CTD PMID:17681415 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of CYP51 mRNA CTD PMID:19429403 permethrin multiple interactions ISO Cyp51 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of CYP51 gene CTD PMID:33148267 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP51 mRNA CTD PMID:19136022 phenobarbital increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of CYP51 mRNA CTD PMID:19162173 phenylephrine increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Phenylephrine results in increased expression of CYP51 mRNA CTD PMID:18158353 phenylpropanolamine increases expression ISO CYP51A1 (Homo sapiens) 6480464 Phenylpropanolamine results in increased expression of CYP51A1 mRNA CTD PMID:27756839 phosgene affects expression EXP 6480464 Phosgene affects the expression of CYP51 mRNA CTD PMID:16300373 phytosterols multiple interactions EXP 6480464 APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP51 mRNA] CTD PMID:18155511 picoxystrobin increases expression ISO CYP51A1 (Homo sapiens) 6480464 picoxystrobin results in increased expression of CYP51A1 mRNA CTD PMID:33512557 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP51 mRNA CTD PMID:19136022 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP51 mRNA and pirinixic acid results in increased expression of CYP51A1 mRNA CTD PMID:17950772 more ... pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP51 mRNA more ... CTD PMID:17950772 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP51 mRNA CTD PMID:18445702 potassium dichromate increases expression ISO CYP51A1 (Homo sapiens) 6480464 Potassium Dichromate results in increased expression of CYP51A1 protein CTD PMID:23718831 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of CYP51 mRNA CTD PMID:27225895 pravastatin increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Pravastatin results in increased expression of CYP51 mRNA CTD PMID:27225895 prochloraz decreases activity ISO CYP51A1 (Homo sapiens) 6480464 prochloraz results in decreased activity of CYP51A1 protein CTD PMID:16989930 progesterone increases expression ISO CYP51A1 (Homo sapiens) 6480464 Progesterone results in increased expression of CYP51A1 mRNA CTD PMID:18070364 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP51 mRNA CTD PMID:16730040 more ... propiconazole increases expression ISO Cyp51 (Rattus norvegicus) 6480464 propiconazole results in increased expression of CYP51 mRNA CTD PMID:28970091 propiconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 propiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 prothioconazole increases expression EXP 6480464 prothioconazole results in increased expression of CYP51 mRNA CTD PMID:29337257 pyrazinecarboxamide increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Pyrazinamide results in increased expression of CYP51 mRNA CTD PMID:22431067 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CYP51A1 mRNA CTD PMID:16455785 quercetin decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Quercetin results in decreased expression of CYP51A1 mRNA CTD PMID:21632981 quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA CTD PMID:18032389 quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA CTD PMID:18032389 quinolin-8-ol decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Oxyquinoline results in decreased expression of CYP51A1 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO CYP51A1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of CYP51A1 mRNA CTD PMID:30851411 Rebamipide increases expression ISO Cyp51 (Rattus norvegicus) 6480464 rebamipide results in increased expression of CYP51 mRNA CTD PMID:18299717 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of CYP51 protein CTD PMID:25505154 resveratrol multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CYP51A1 mRNA CTD PMID:23557933 ritodrine decreases expression EXP 6480464 Ritodrine results in decreased expression of CYP51 mRNA CTD PMID:23370008 ritonavir increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Ritonavir results in increased expression of CYP51 mRNA CTD PMID:17719200 rotenone decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Rotenone results in decreased expression of CYP51 mRNA CTD PMID:28374803 rotenone increases expression ISO CYP51A1 (Homo sapiens) 6480464 Rotenone results in increased expression of CYP51A1 mRNA CTD PMID:33512557 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CYP51 mRNA CTD PMID:29203145 silver atom decreases expression EXP 6480464 Silver results in decreased expression of CYP51 mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of CYP51 mRNA CTD PMID:27131904 simvastatin increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Simvastatin results in increased expression of CYP51 mRNA CTD PMID:25055962 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP51 mRNA CTD PMID:32045263 sodium dodecyl sulfate decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA CTD PMID:12815608 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of CYP51A1 protein CTD PMID:28918527 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA CTD PMID:21641980 and PMID:26378955 sulfadimethoxine increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of CYP51 mRNA CTD PMID:30047161 sunitinib increases expression ISO CYP51A1 (Homo sapiens) 6480464 Sunitinib results in increased expression of CYP51A1 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of CYP51 mRNA CTD PMID:20937368 tebuconazole decreases activity ISO CYP51A1 (Homo sapiens) 6480464 tebuconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP51 mRNA CTD PMID:29337257 tebufenpyrad decreases expression ISO CYP51A1 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CYP51A1 mRNA CTD PMID:33512557 temozolomide decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Temozolomide results in decreased expression of CYP51A1 mRNA CTD PMID:31758290 testosterone decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Testosterone results in decreased expression of CYP51A1 mRNA CTD PMID:33359661 tetrachloromethane affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of CYP51 mRNA CTD PMID:15963342 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP51 mRNA CTD PMID:31919559 tetrachloromethane decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CYP51 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP51 mRNA CTD PMID:30517762 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of CYP51 mRNA CTD PMID:16917069 thapsigargin increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Thapsigargin results in increased expression of CYP51 protein CTD PMID:35544339 thioacetamide increases methylation ISO Cyp51 (Rattus norvegicus) 6480464 Thioacetamide results in increased methylation of CYP51 promoter CTD PMID:27914986 thioacetamide decreases expression ISO Cyp51 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CYP51 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CYP51 mRNA CTD PMID:23409001 tolcapone increases expression ISO Cyp51 (Rattus norvegicus) 6480464 tolcapone results in increased expression of CYP51 mRNA CTD PMID:24136188 toluene affects expression ISO Cyp51 (Rattus norvegicus) 6480464 Toluene affects the expression of CYP51 mRNA CTD PMID:18653662 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of CYP51 mRNA CTD PMID:29279043 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP51 mRNA CTD PMID:17178688 more ... triadimefon decreases activity ISO CYP51A1 (Homo sapiens) 6480464 triadimefon results in decreased activity of CYP51A1 protein CTD PMID:16989930 triadimefon increases expression ISO Cyp51 (Rattus norvegicus) 6480464 triadimefon results in increased expression of CYP51 mRNA CTD PMID:17178689 trichloroethene increases expression ISO Cyp51 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of CYP51 mRNA CTD PMID:33387578 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of CYP51 mRNA CTD PMID:19042947 triphenyl phosphate affects expression ISO Cyp51 (Rattus norvegicus) 6480464 triphenyl phosphate affects the expression of CYP51 mRNA CTD PMID:30589522 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP51 mRNA CTD PMID:32835833 valdecoxib increases expression ISO Cyp51 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of CYP51 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO CYP51A1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of CYP51A1 gene CTD PMID:29154799 valproic acid decreases expression ISO CYP51A1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP51A1 mRNA CTD PMID:23179753 and PMID:27188386 valproic acid affects expression ISO CYP51A1 (Homo sapiens) 6480464 Valproic Acid affects the expression of CYP51A1 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP51 mRNA CTD PMID:22045034 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CYP51 mRNA CTD PMID:17292431 and PMID:17963808 vancomycin increases expression EXP 6480464 Vancomycin results in increased expression of CYP51 mRNA CTD PMID:18930951 vinclozolin affects expression ISO Cyp51 (Rattus norvegicus) 6480464 vinclozolin affects the expression of CYP51 mRNA CTD PMID:19015723 vinclozolin increases expression ISO Cyp51 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of CYP51 mRNA CTD PMID:22570695 and PMID:23034163 voriconazole decreases response to substance ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene results in decreased susceptibility to Voriconazole CTD PMID:18694951 voriconazole multiple interactions ISO CYP51A1 (Homo sapiens) 6480464 CYP51A1 gene inhibits the reaction [Voriconazole results in decreased chemical synthesis of Ergosterol] more ... CTD PMID:18694951 Yessotoxin increases expression ISO CYP51A1 (Homo sapiens) 6480464 yessotoxin analog results in increased expression of CYP51A1 mRNA CTD PMID:30679557 zaragozic acid A increases expression ISO Cyp51 (Rattus norvegicus) 6480464 squalestatin 1 results in increased expression of CYP51 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP51 mRNA CTD PMID:27225895 zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of CYP51 protein CTD PMID:25058043 zoledronic acid increases expression ISO CYP51A1 (Homo sapiens) 6480464 zoledronic acid results in increased expression of CYP51A1 mRNA CTD PMID:24714768